{"protocolSection":{"identificationModule":{"nctId":"NCT02657070","orgStudyIdInfo":{"id":"CEIC 53/2013"},"organization":{"fullName":"Universitat Pompeu Fabra","class":"OTHER"},"briefTitle":"Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)","officialTitle":"Desaprendiendo la parÃ¡lisis Aprendida Con RGS en Pacientes Afectos de Ictus"},"statusModule":{"statusVerifiedDate":"2016-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2014-03"},"primaryCompletionDateStruct":{"date":"2015-08","type":"ACTUAL"},"completionDateStruct":{"date":"2015-08","type":"ACTUAL"},"studyFirstSubmitDate":"2016-01-13","studyFirstSubmitQcDate":"2016-01-14","studyFirstPostDateStruct":{"date":"2016-01-15","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-01-14","lastUpdatePostDateStruct":{"date":"2016-01-15","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Paul Verschure","investigatorTitle":"Prof.","investigatorAffiliation":"Universitat Pompeu Fabra"},"leadSponsor":{"name":"Universitat Pompeu Fabra","class":"OTHER"},"collaborators":[{"name":"Hospital Universitari Joan XXIII de Tarragona.","class":"OTHER"}]},"descriptionModule":{"briefSummary":"The purpose of this study is to determine if Reinforcement-Induced Movement Therapy (RIMT), a novel rehabilitation method that augments visuomotor feedback of movements of the patient in virtual reality, is effective in treating hemiparesis resp. learned non-use."},"conditionsModule":{"conditions":["Hemiparesis"],"keywords":["Stroke","learned non-use","Virtual Reality","Hemiparesis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":23,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Experimental Group","type":"EXPERIMENTAL","description":"Virtual reality based therapy with augmented visuomotor feedback.","interventionNames":["Behavioral: Reinforcement-Induced Movement Therapy (RIMT)"]},{"label":"Control Group","type":"ACTIVE_COMPARATOR","description":"Virtual reality based therapy without augmentation.","interventionNames":["Behavioral: VR-based motor rehabilitation in RGS without augmented feedback"]}],"interventions":[{"type":"BEHAVIORAL","name":"Reinforcement-Induced Movement Therapy (RIMT)","description":"6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS) with augmented visuomotor feedback","armGroupLabels":["Experimental Group"],"otherNames":["VR-based motor rehabilitation in RGS with amplified visuomotor feedback"]},{"type":"BEHAVIORAL","name":"VR-based motor rehabilitation in RGS without augmented feedback","description":"6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS)","armGroupLabels":["Control Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The upper extremity Fugl-Meyer Assessment","description":"change from baseline in motor function","timeFrame":"at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up"}],"secondaryOutcomes":[{"measure":"Chedoke Arm Hand Inventory","description":"change from baseline in functional recovery","timeFrame":"at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up"},{"measure":"Barthel Index","description":"change from baseline in activities of daily living","timeFrame":"at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up"},{"measure":"Hamilton Scale","description":"change from baseline in measurement of depression","timeFrame":"at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Mild-to-moderate upper-limbs hemiparesis (Proximal Medical Research Council Scale \\> 2) due to ischemic or hemorrhagic stroke\n* Spasticity in the affected limb (Modified Ashworth Scale \\<3)\n* First-ever ischemic or hemorrhagic stroke (\\>4 weeks post-stroke)\n* Sufficient cognitive capacity for following the instruction of the intervention (Mini-Mental State Evaluation \\>24)\n\nExclusion Criteria:\n\n* Cognitive impairment that impede the correct execution or understanding of the intervention\n* Severe impairments in vision or visual perception abilities (such as vision loss or spatial neglect), in spasticity, in communication abilities (such as aphasia or apraxia), severe pain as well as other neuromuscular or orthopedic changes that impede the correct execution of the intervention training\n* Mental dysfunctioning during the acute or subacute phase after the stroke.","healthyVolunteers":false,"sex":"ALL","minimumAge":"25 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Rosa Maria San Segundo Mozo, Dra.","affiliation":"Medico Especialista en Medician Fisica y Rehabilitation, Doctora por al Universitat Rovira i Virgili de Tarragona","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Paul F.M.J. Verschure, Prof.","affiliation":"Director SPECS","role":"STUDY_DIRECTOR"}]},"referencesModule":{"references":[{"pmid":"10714655","type":"BACKGROUND","citation":"Ramachandran VS, Rogers-Ramachandran D. Phantom limbs and neural plasticity. Arch Neurol. 2000 Mar;57(3):317-20. doi: 10.1001/archneur.57.3.317."},{"pmid":"7886714","type":"BACKGROUND","citation":"de Haan RJ, Limburg M, Van der Meulen JH, Jacobs HM, Aaronson NK. Quality of life after stroke. Impact of stroke type and lesion location. Stroke. 1995 Mar;26(3):402-8. doi: 10.1161/01.str.26.3.402."},{"pmid":"16480566","type":"BACKGROUND","citation":"Thomas SA, Lincoln NB. Factors relating to depression after stroke. Br J Clin Psychol. 2006 Mar;45(Pt 1):49-61. doi: 10.1348/014466505X34183."},{"pmid":"26684921","type":"BACKGROUND","citation":"Robinson RG, Jorge RE. Post-Stroke Depression: A Review. Am J Psychiatry. 2016 Mar 1;173(3):221-31. doi: 10.1176/appi.ajp.2015.15030363. Epub 2015 Dec 18."},{"pmid":"27506203","type":"DERIVED","citation":"Ballester BR, Maier M, San Segundo Mozo RM, Castaneda V, Duff A, M J Verschure PF. Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy. J Neuroeng Rehabil. 2016 Aug 9;13(1):74. doi: 10.1186/s12984-016-0178-x."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000010291","term":"Paresis"}],"ancestors":[{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M20634","name":"Muscle Weakness","relevance":"LOW"},{"id":"M12894","name":"Paresis","asFound":"Hemiparesis","relevance":"HIGH"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}